Literature DB >> 30719198

Major concerns remain around pay-for-performance programs in Canada.

.   

Abstract

Year:  2018        PMID： 30719198      PMCID： PMC6346338          DOI： 10.1177/1715163518816666

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  4 in total

1.  The problem with pay-for-performance schemes.

Authors:  Suhas Gondi; Derek Soled; Ashish Jha
Journal:  BMJ Qual Saf       Date:  2018-07-30       Impact factor: 7.035

Review 2.  Effects of pay for performance in health care: a systematic review of systematic reviews.

Authors:  Frank Eijkenaar; Martin Emmert; Manfred Scheppach; Oliver Schöffski
Journal:  Health Policy       Date:  2013-02-04       Impact factor: 2.980

3.  Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Authors:  Sherilyn K D Houle; Theresa L Charrois; Finlay A McAlister; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norman R C Campbell; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2016-10-03

Review 4.  Pay-for-performance in disease management: a systematic review of the literature.

Authors:  Simone R de Bruin; Caroline A Baan; Jeroen N Struijs
Journal:  BMC Health Serv Res       Date:  2011-10-14       Impact factor: 2.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.